Market Overview:
The global chemical medication in COVID-19 market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing incidences of COVID-19, rising demand for novel therapeutics, and growing investments by key players. Based on type, the global chemical medication in COVID-19 market is segmented into remedsivir, ardidol, favipivir, lopinavir/ritonavir (LPV/r), chloroquine and others. Remedsivir accounted for a major share of the overall market in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to its high efficacy as well as safety profile. Favipivir is another key player in this segment owing to its ability to inhibit SARS CoV replication without causing any adverse effects on cellular functions. Based on application, the global chemical medication in COVID-19 market is segmented into COVID-19 treatment & prophylaxis; influenza treatment & prophylaxis; malaria treatment & prophylaxis; and others including tuberculosis (TB) and dengue fever.
Product Definition:
Chemical Medication is the use of medication to treat or prevent an illness or medical condition. The importance of Chemical Medication in COVID-19 is that it can help to prevent and treat the virus.
Remedsivir:
Remediation of the COVID-19 virus consists of a combination of antiviral agents, which are used to treat coronavirus disease. The current treatment paradigm for COVID-19 has been based on three pillars: Airborne, Oral and Inhaled Antiviral Medications. Currently there is no cure for the infection; however, research is being conducted to develop one.
Ardidol:
Ardidol is a chemical compound that works as an interferon. It is manufactured by the fermentation of bacteria in a controlled environment. The FDA approved it for usage as an antiviral medication to treat influenza B and C infections, but not for COVID-19 treatment due to lack of scientific evidence. However, there are several studies underway to determine its efficacy and safety in COVID-19 patients which will help provide clinical support for its use during this pandemic.
Application Insights:
Based on the application, the global market is segmented into COVID-19, influenza, malaria and others. The COVID-19 segment dominated the overall market in terms of revenue share in 2017. Increasing cases of new onset flu like symptoms has resulted in high demand for medication to treat co-infections such as pneumonia and kidney problems. As per WHO estimates, over 250 million people were suffering from some form of chronic disease or another across all regions globally as of 2016. This fact sheet provides an insight into prevalence rates for selected chronic diseases by region along with mortality rates and life expectancy at birth between 2016 - 2020 ¢â‚¬â€œ 2030 ¢â‚¬ Global Burden Disease Report (2016 - 2020).
Regional Analysis:
North America dominated the global market in 2018, with a revenue share of over 35.0%. Key factors contributing to its high share include the presence of key players, availability of advanced technologies and early adoption. The region is expected to witness considerable growth during the forecast period due to increasing COVID-19 cases in U.S., which has led to an increase in demand for chemotherapies and other medication used for treatment purposes.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to rising healthcare expenditure by governments as well as private sectors across countries such as China, India, Japan & Australia among others (APAC). Moreover, increasing awareness about COVID-19 infection among people will also boost regional market growth over next eight years from 2018 till 2030 time frame.
Growth Factors:
- Increased demand from hospitals and clinics for chemical medication to treat COVID-19 patients.
- Rise in public awareness of the benefits of chemical medication over traditional treatments for COVID-19.
- More research being conducted on the efficacy of different types of chemical medication in treating COVID-19 patients.
- Pharmaceutical companies increasing production capacity for various types of chemical medications to meet rising demand from consumers and healthcare providers alike
Scope Of The Report
Report Attributes
Report Details
Report Title
Chemical Medication in COVID-19 Market Research Report
By Type
Remedsivir, Ardidol, Favipivir, Lopinavir/ritonavir (LPV/r), Chloroquine, Others
By Application
COVID-19, Influenza, Malaria, Others
By Companies
Gilead Sciences, AbbVie, Johnson & Johnson, Pfizer, Mylan, Bayer, Zhejiang Hisun, CSPC Pharmaceutical Group, Reyoung Pharmaceutical, Sihuan Pharmaceutical, Hikma Pharmaceuticals, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Guangzhou Baiyunshan Guanghua Pharmaceutical, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Chemical Medication in COVID-19 Market Report Segments:
The global Chemical Medication in COVID-19 market is segmented on the basis of:
Types
Remedsivir, Ardidol, Favipivir, Lopinavir/ritonavir (LPV/r), Chloroquine, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
COVID-19, Influenza, Malaria, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Gilead Sciences
- AbbVie
- Johnson & Johnson
- Pfizer
- Mylan
- Bayer
- Zhejiang Hisun
- CSPC Pharmaceutical Group
- Reyoung Pharmaceutical
- Sihuan Pharmaceutical
- Hikma Pharmaceuticals
- Rising Pharmaceutical
- Sun Pharma
- Shanghai Pharma
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- KPC Group
- Jinghua Pharmaceutical Group
- Zhongsheng Pharma
- North China Pharmaceutical Group
Highlights of The Chemical Medication in COVID-19 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Remedsivir
- Ardidol
- Favipivir
- Lopinavir/ritonavir (LPV/r)
- Chloroquine
- Others
- By Application:
- COVID-19
- Influenza
- Malaria
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chemical Medication in COVID-19 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chemical medication is any drug or other substance that is used to treat a medical condition.
Some of the major players in the chemical medication in covid-19 market are Gilead Sciences, AbbVie, Johnson & Johnson, Pfizer, Mylan, Bayer, Zhejiang Hisun, CSPC Pharmaceutical Group, Reyoung Pharmaceutical, Sihuan Pharmaceutical, Hikma Pharmaceuticals, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Guangzhou Baiyunshan Guanghua Pharmaceutical, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chemical Medication in COVID-19 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chemical Medication in COVID-19 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chemical Medication in COVID-19 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chemical Medication in COVID-19 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chemical Medication in COVID-19 Market Size & Forecast, 2018-2028
4.5.1 Chemical Medication in COVID-19 Market Size and Y-o-Y Growth
4.5.2 Chemical Medication in COVID-19 Market Absolute $ Opportunity
Chapter 5 Global Chemical Medication in COVID-19 Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chemical Medication in COVID-19 Market Size Forecast by Type
5.2.1 Remedsivir
5.2.2 Ardidol
5.2.3 Favipivir
5.2.4 Lopinavir/ritonavir (LPV/r)
5.2.5 Chloroquine
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chemical Medication in COVID-19 Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chemical Medication in COVID-19 Market Size Forecast by Applications
6.2.1 COVID-19
6.2.2 Influenza
6.2.3 Malaria
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chemical Medication in COVID-19 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chemical Medication in COVID-19 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chemical Medication in COVID-19 Analysis and Forecast
9.1 Introduction
9.2 North America Chemical Medication in COVID-19 Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chemical Medication in COVID-19 Market Size Forecast by Type
9.6.1 Remedsivir
9.6.2 Ardidol
9.6.3 Favipivir
9.6.4 Lopinavir/ritonavir (LPV/r)
9.6.5 Chloroquine
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chemical Medication in COVID-19 Market Size Forecast by Applications
9.10.1 COVID-19
9.10.2 Influenza
9.10.3 Malaria
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chemical Medication in COVID-19 Analysis and Forecast
10.1 Introduction
10.2 Europe Chemical Medication in COVID-19 Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chemical Medication in COVID-19 Market Size Forecast by Type
10.6.1 Remedsivir
10.6.2 Ardidol
10.6.3 Favipivir
10.6.4 Lopinavir/ritonavir (LPV/r)
10.6.5 Chloroquine
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chemical Medication in COVID-19 Market Size Forecast by Applications
10.10.1 COVID-19
10.10.2 Influenza
10.10.3 Malaria
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chemical Medication in COVID-19 Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chemical Medication in COVID-19 Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chemical Medication in COVID-19 Market Size Forecast by Type
11.6.1 Remedsivir
11.6.2 Ardidol
11.6.3 Favipivir
11.6.4 Lopinavir/ritonavir (LPV/r)
11.6.5 Chloroquine
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chemical Medication in COVID-19 Market Size Forecast by Applications
11.10.1 COVID-19
11.10.2 Influenza
11.10.3 Malaria
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chemical Medication in COVID-19 Analysis and Forecast
12.1 Introduction
12.2 Latin America Chemical Medication in COVID-19 Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chemical Medication in COVID-19 Market Size Forecast by Type
12.6.1 Remedsivir
12.6.2 Ardidol
12.6.3 Favipivir
12.6.4 Lopinavir/ritonavir (LPV/r)
12.6.5 Chloroquine
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chemical Medication in COVID-19 Market Size Forecast by Applications
12.10.1 COVID-19
12.10.2 Influenza
12.10.3 Malaria
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chemical Medication in COVID-19 Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chemical Medication in COVID-19 Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chemical Medication in COVID-19 Market Size Forecast by Type
13.6.1 Remedsivir
13.6.2 Ardidol
13.6.3 Favipivir
13.6.4 Lopinavir/ritonavir (LPV/r)
13.6.5 Chloroquine
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chemical Medication in COVID-19 Market Size Forecast by Applications
13.10.1 COVID-19
13.10.2 Influenza
13.10.3 Malaria
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chemical Medication in COVID-19 Market: Competitive Dashboard
14.2 Global Chemical Medication in COVID-19 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Gilead Sciences
14.3.2 AbbVie
14.3.3 Johnson & Johnson
14.3.4 Pfizer
14.3.5 Mylan
14.3.6 Bayer
14.3.7 Zhejiang Hisun
14.3.8 CSPC Pharmaceutical Group
14.3.9 Reyoung Pharmaceutical
14.3.10 Sihuan Pharmaceutical
14.3.11 Hikma Pharmaceuticals
14.3.12 Rising Pharmaceutical
14.3.13 Sun Pharma
14.3.14 Shanghai Pharma
14.3.15 Guangzhou Baiyunshan Guanghua Pharmaceutical
14.3.16 KPC Group
14.3.17 Jinghua Pharmaceutical Group
14.3.18 Zhongsheng Pharma
14.3.19 North China Pharmaceutical Group
